Clinical Trial Update: Efficacy Study of LY2422347 to Treat Insomnia [Phase 2]

View source ↗

Summary

A Phase 2 efficacy study of LY2422347 for insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• LY2422347

Snippet

Sponsor: Eli Lilly and Company | Conditions: Sleep Initiation and Maintenance Disorders | Phase 2 | Status: COMPLETED